These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1419827)

  • 21. Iron chelators may enhance erythropoiesis by increasing iron delivery to haematopoietic tissue and erythropoietin response in iron-loading anaemia.
    Vreugdenhil G; Smeets M; Feelders RA; van Eijk HG
    Acta Haematol; 1993; 89(2):57-60. PubMed ID: 8503244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment.
    Donnelly SM; Smith EK
    Am J Kidney Dis; 1990 Nov; 16(5):487-90. PubMed ID: 2239943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
    Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
    Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.
    Winearls CG; Oliver DO; Pippard MJ; Reid C; Downing MR; Cotes PM
    Lancet; 1986 Nov; 2(8517):1175-8. PubMed ID: 2877323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patients.
    Kooistra MP; Marx JJ
    Nephrol Dial Transplant; 1998 Oct; 13(10):2578-82. PubMed ID: 9794563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral iron absorption in hemodialysis patients treated with erythropoietin.
    Donnelly SM; Posen GA; Ali MA
    Clin Invest Med; 1991 Aug; 14(4):271-6. PubMed ID: 1782724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.
    Stoves J; Inglis H; Newstead CG
    Nephrol Dial Transplant; 2001 May; 16(5):967-74. PubMed ID: 11328902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of the response of elderly patients with end-stage renal disease to epoetin alfa or beta.
    Nicholas JC
    Drugs Aging; 2004; 21(3):187-201. PubMed ID: 14979736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of renal anaemia with erythropoiesis-stimulating agents in predialysis chronic kidney disease patients: Haemoglobin profile during the 6 months before initiation of dialysis.
    Kawahara K; Minakuchi J; Yokota N; Suekane H; Tsuchida K; Kawashima S
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():29-32. PubMed ID: 26456375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics.
    Cotes PM; Pippard MJ; Reid CD; Winearls CG; Oliver DO; Royston JP
    Q J Med; 1989 Feb; 70(262):113-37. PubMed ID: 2594953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron monitoring and supplementation: how do we achieve the best results?
    Schaefer RM; Schaefer L
    Nephrol Dial Transplant; 1998; 13 Suppl 2():9-12. PubMed ID: 9566484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
    Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW
    N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased iron absorption in patients with active rheumatoid arthritis, with and without iron deficiency.
    Weber J; Werre JM; Julius HW; Marx JJ
    Ann Rheum Dis; 1988 May; 47(5):404-9. PubMed ID: 3389928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved response to erythropoietin therapy with long-term continuous iron supplementation.
    Descombes E; Fellay G
    Nephron; 2000 Feb; 84(2):196-7. PubMed ID: 10657727
    [No Abstract]   [Full Text] [Related]  

  • 36. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
    Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of azathioprine on the ferrokinetics of patients with renal failure before and after treatment with erythropoietin.
    Anastassiades E; Howarth D; Howarth JE; Shanks D; Waters HM; Hyde K; Yin JA; Geary CG; Gokal R
    Nephron; 1994; 67(3):291-6. PubMed ID: 7936018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
    Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
    Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin.
    Markowitz GS; Kahn GA; Feingold RE; Coco M; Lynn RI
    Clin Nephrol; 1997 Jul; 48(1):34-40. PubMed ID: 9247776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron management during recombinant human erythropoietin therapy.
    Van Wyck DB
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):9-13. PubMed ID: 2757026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.